Search

In a Bloomberg article titled, “Cannabis Industry Enjoys a Rare Moment of Progress,” Partner Zachary Kobrin discussed the implications of last week’s news that the U.S. Department of Health and Human Services is recommending looser restrictions for cannabis producers. Kobrin, who is based in Fort...

In a recent letter to the Drug Enforcement Administration (DEA), the Department of Health and Human Services (HHS) recommended that cannabis be reclassified as a Schedule III drug under the Controlled Substances Act. The DEA will conduct its own review of HHS’s findings before officially determining...